GSA CAPITAL PARTNERS LLP

Position in NUVB — Nuvation Bio Inc.

CIK 1362033 LONDON, X0

Position in NUVB

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$2,126,947

+$2,000,513 QoQ

Shares Held

495,792

+3413.5% QoQ

Ownership

0.142%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $101,563,069 across 163 Biotechnology names. NUVB ranks #4 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,831	$2,959,983
2	ARDX	Ardelyx, Inc.	473,061	$2,833,635
3	NTLA	Intellia Therapeutics, Inc.	178,301	$2,285,818
4	NUVB	Nuvation Bio Inc. This page	495,792	$2,126,947
5	RXRX	Recursion Pharmaceuticals, Inc.	669,568	$2,055,573
6	WVE	Wave Life Sciences Ltd.	282,719	$2,049,712
7	SRPT	Sarepta Therapeutics, Inc.	90,960	$1,979,289
8	IOVA	Iovance Biotherapeutics, Inc.	557,085	$1,955,368

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,126,947	495,792	+3413.5%	Shares	Sole	2026-05-08
2025-12-31	$126,434	14,111	-98.6%	Shares	Sole	2026-02-06
2025-09-30	$3,830,210	1,035,192	-36.4%	Shares	Sole	2025-11-07
2025-06-30	$3,172,887	1,627,122	+146.1%	Shares	Sole	2025-07-22
2025-03-31	$1,163,451	661,052	+172.9%	Shares	Sole	2025-05-08
2024-12-31	$644,392	242,253	+223.3%	Shares	Sole	2025-02-07
2024-09-30	$171,594	74,932	+75.2%	Shares	Sole	2024-11-05
2023-12-31	$64,591	42,776	-81.4%	Shares	Sole	2024-02-16
2023-09-30	$308,595	230,295	-16.8%	Shares	Sole	2023-11-15
2023-06-30	$498,033	276,685	-13.1%	Shares	Sole	2023-08-14
2023-03-31	$528,816	318,564	+28.7%	Shares	Sole	2023-05-12
2022-12-31	$475,278	247,541	+24.8%	Shares	Sole	2023-02-13
2022-09-30	$444,364	198,377	+471.0%	Shares	Sole	2022-11-14
2022-06-30	$112,564	34,742	—	Shares	Sole	2022-08-09
No filing history on record for this holder in this stock.